Figure 3.Variability analysis of immunoregulation-related pathways. (A) Differential analysis of variability scores of immunoregulation-related pathways in GSEA. (B) Survival analysis of the SIG_BCR_SIGNALING_PATHWAY and SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES in patients with LUAD. (C) Enrichment significance analysis of B Cell activation and immunoregulatory pathways.
